News
Rob Nixon joins Qkine as Head of Commercial and Dr Cassie Doherty is appointed to the board
Cambridge, UK 21 July 2020: Qkine – a specialist developer and manufacturer of proteins for stem cell, organoid and regenerative medicine applications […]
Video: Growth factor purity and its implications for stem cell culture
Presentation by Luana Ferrara, Senior Protein Scientist Video script Slide 1: Introduction Hello! My name is Luana Ferrara and I am a senior protein […]
Qkine secures £1.5M series A funding from leading life science investors
Cambridge, UK 08 June 2020: Qkine – a specialist developer and manufacturer of proteins for stem cell, organoid and regenerative medicine applications […]
Qkine secures additional £550K to extend development of R&D pipeline and accelerate commercialisation of product portfolio
Cambridge, UK 03 June 2019: Qkine, specialist manufacturer of proteins for stem cell, organoid and regenerative medicine applications, has closed a […]
Why quality is not just about purity – by Qkine founder Dr Marko Hyvönen
As a structural biologist, one will very quickly realise that protein not only needs to be pure, but it needs to be also homogeneous and the real proof of the protein’s quality is in its specific bioactivity. So,we clearly need different criteria for defining quality and that is what we do at Qkine.
So what does the “i” in iteams mean?
Running for over a decade, the iteams programme partners multi-disciplinary teams of PhD students and postdocs with inventors from the University of […]
Building next generation growth factors for organoid-driven precision medicine: a protein engineering project co-funded by Innovate UK
We were delighted to be awarded Innovate UK funding to address issues of quality and availability of growth factors for use in organoid technologies. The Qkine R&D team are applying a combination of protein expression, refolding optimisation and structure-guided protein engineering to improve the biological properties and quality of proteins such as R-spondins, TGFβ1, members of the BMP and FGF family proteins.
Qkine backed by Cambridge Enterprise and a quintet of angels
University of Cambridge spin-out Qkine has closed its seed investment round supported by Cambridge Enterprise, the commercialisation arm of the University, and a […]
Cambridge Enterprise and Qkine Ltd sign deal to drive stem cell and regenerative medicine research
Cambridge Enterprise and specialist growth factor manufacturer Qkine Ltd sign key licensing deal for Activin A production technology
- « Previous
- 1
- …
- 8
- 9
- 10